SHANGHAI, May 3, 2017 /PRNewswire/ -- CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors, has announced the opening of its new manufacturing facility in Shanghai.